InvestorsHub Logo
Followers 0
Posts 484
Boards Moderated 0
Alias Born 10/10/2014

Re: gr8db8 post# 1092

Monday, 07/17/2017 4:01:28 PM

Monday, July 17, 2017 4:01:28 PM

Post# of 2099
Notice the wording "a better planned randomized phase 2 BRAIN trial". You would think a company like Genentech/Roche have extensive experience in designing trials .... unless they intentionally designed the trial so that the data worked favorably for them. Seems like that strategy work for them ... billions for them and no improvement in mOS for the patients. This is all about greed and nothing to do with improving healthcare.

Biosimilars are taking their market share and hopefully VB-111 does too.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VBLT News